Interestingly, Raschi et al, showed that immune complexes from patients with SSc containing ATA upregulated TLR4 expression and increased activation of SAPK-JNK, p38MAPK and Akt signalling via an Fc-gamma-receptor independent mechanism which engaged endothelial damage.28 The gene discussed is MAPK9; the disease is systemic sclerosis.